Skip to main content
Government of Quebec
Institut national de santé publique du Québec
Français
FR
Home
Navigation principale
The Institute
The Institute
About us
About us
Products and services offered
Back
Contact us
Contact us
Workplaces
Back
Exit
Back
Expertise
Expertise
Information management and analysis
Information management and analysis
Deprivation
Deprivation
Indices of multiple and multidimensional deprivation
Material and Social Deprivation Index
Back
Back
Individual and community development
Individual and community development
Perinatal and early childhood
Perinatal and early childhood
From Tiny Tot to Toddler
Back
Back
Lifestyles
Lifestyles
Alimentation
Alimentation
Health-promoting environments
Back
Back
Psychoactive substances, tobacco and gambling
Psychoactive substances, tobacco and gambling
Drugs and medicines
Drugs and medicines
Opioid overdoses
Back
Tobacco and electronic cigarettes
Tobacco and electronic cigarettes
Science Watch : Tobacco Control
Back
Back
Infectious diseases
Infectious diseases
Respiratory infectious diseases
Respiratory infectious diseases
Données des virus respiratoires
COVID-19 (coronavirus)
Back
Prevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections
Nosocomial infections
Back
Travel-health
Travel-health
Health tips for travellers
Back
Zoonoses and emerging diseases
Zoonoses and emerging diseases
Diseases transmitted by ticks
Back
Back
Occupational health
Occupational health
Work-related respiratory diseases
Work-related respiratory diseases
Asbestos
Back
Psychosocial risks in the workplace
Psychosocial risks in the workplace
Let's get started
Back
Back
Indigenous Health
Indigenous Health
Research Monitoring
Research Monitoring
Methodology for Indigenous Health Research Monitoring
Back
Nunavik Inuit Health Survey 2004
Back
Environmental Health
Environmental Health
Air quality
Air quality
Indoor air
Back
Back
Safety, violence and injury prevention
Safety, violence and injury prevention
Community safety promotion
Community safety promotion
Methods and tools
Back
Prevention of interpersonal violence
Prevention of interpersonal violence
Sexual Violence
Rapport québécois sur la violence et la santé
Back
Back
Exit
Back
Services
Services
Centre de toxicologie du Québec
Centre de toxicologie du Québec
About the CTQ
About the CTQ
Contact us
Back
Services
Services
Test catalog
Analysis request forms
Shipping samples
PayPal Bill Payment
Back
External quality assessment schemes
External quality assessment schemes
AMAP: AMAP Ring Test for Persistent Organic Pollutants in Human Serum
Creatinine: Interlaboratory Comparison Program for Measurement of Serum Creatinine
OSEQAS: External Quality Assessment Scheme for Organic Substances in Urine
PCI: Interlaboratory Comparison Program for Metals in Biological Matrices
QMEQAS: Quebec Multielement External Quality Assessment Scheme
Back
Back
Infectious diseases
Infectious diseases
Blood-Borne Infection Risk Assessment Unit
Blood-Borne Infection Risk Assessment Unit
Risk Assessment Process
Rights and Responsibilities
Back
Back
Exit
Back
Publications
Publications
Publications
Subscribe to INSPQ's mailing lists
Exit
Back
Surveys
Surveys
Respiratory viruses survey
Respiratory viruses survey
Complete the survey (period from October 19 to 25, 2025)
Back
Exit
Back
Danger page
Search
Search by keywords
Content type
Content type
Data
Internship
Laboratory analysis
News
Newsletter
Page
Publication
Tiny Tot
Training
Chantal Sauvageau
Publications
INSPQ
2020
Vaccination contre l’hépatite A des enfants nés d’avril 2013 à mai 2019
Les activités de vaccination en période de pandémie de COVID-2019 - Version 2.0 du 6 mai 2020
Mesures à mettre en place pour les hôtels qui accueilleront des personnes en isolement volontaire ou obligatoire (asymptomatiques) ou des personnes atteintes de COVID-19 ou sous investigation qui ne peuvent être isolées à la maison
2025
Protection contre les infections persistantes VPH 16/18 jusqu’à 13 ans après la vaccination de filles de 9-11 ans avec 2 ou 3 doses du vaccin quadrivalent selon un calendrier allongé : rapport de l’étude ICI-VPH
Analyse du volet québécois de l'étude Engage pour soutenir l'évaluation du programme de vaccination contre les virus du papillome humain (VPH) chez les hommes gbHARSAH
Prévalence des génotypes des virus du papillome humain chez les garçons non vaccinés âgés de 16 à 20 ans au Québec
2024
Vaccination contre la COVID-19 : Recommandations pour l’automne 2024
Avis complémentaire sur le choix des vaccins influenza pour l’immunisation des personnes âgées et vulnérables durant la saison 2024-2025 au Québec
Calendrier de vaccination contre les virus du papillome humain pour les personnes âgées de 20 ans et moins au Québec
2023
Incidence et gravité du syndrome inflammatoire multisystémique de l’enfant au cours de la vague Omicron
2022
Vaccination contre la COVID-19 chez les enfants âgés de 6 mois à 4 ans au Québec
Vaccination contre l’influenza et la COVID-19 à l’automne 2022
Calendrier de vaccination contre les virus du papillome humain pour les personnes âgées de 18 ans et plus au Québec
Avis concernant l’usage d’une dose de rappel du vaccin Comirnaty pédiatrique contre la COVID-19 chez les enfants de 5 à 11 ans
Revue rapide de la littérature scientifique sur le fardeau de la COVID-19 et les facteurs associés à la gravité de la maladie chez les enfants de 0 à 4 ans
Fardeau de la varicelle et du zona à la suite de l’introduction du programme de vaccination contre la varicelle à une puis à deux doses au Québec
Vaccination contre la COVID-19 chez les jeunes âgés de 5 à 11 ans au Québec
Dose de rappel de vaccin contre la COVID-19 chez les jeunes âgés de 12 à 17 ans
COVID-19 : Transmission extérieure
2021
Revue rapide de la littérature et données épidémiologiques provinciales de la COVID-19 parmi les jeunes âgés de moins de 18 ans
Vaccination des personnes de moins de 30 ans contre la COVID-19 dans le contexte de la survenue de myocardites et péricardites après l’administration des vaccins à ARN messager
Pertinence d’une dose de vaccin à ARN messager contre la COVID-19 chez les personnes ayant reçu un vaccin à vecteur viral pour la série primaire
Efficacité d’une dose de vaccin contre la COVID-19 chez les personnes de 60 ans et plus vivant dans la communauté au Québec
Impact de la première dose de vaccin contre la COVID-19 dans les CHSLD et les RPA
Proposition de mesures à déployer dans les écoles primaires et secondaires afin de réduire la transmission de la COVID-19 et assurer une scolarisation en présentiel pour l’année 2021-2022
SARS-CoV-2 transmission: Findings and proposed terminology
Transmission du SRAS-CoV-2 : constats et proposition de terminologie
2019
Évaluation du webinaire sur la vaccination contre les virus du papillome humain (VPH) pour les infirmières scolaires - 2018
Évaluation du webinaire sur la vaccination contre les virus du papillome humain (VPH) pour les infirmières scolaires – 2017
Groupes supplémentaires qui pourraient être visés par une vaccination gratuite contre les virus du papillome humain (VPH)
Portrait de l’incidence et de la mortalité des cancers associés aux virus du papillome humain (VPH) : mise à jour de l’incidence 2008-2010 et de la mortalité 2008-2012
2016
Prévalence des infections au virus du papillome humain (VPH) : résultats de l’étude PIXEL - Portrait de la santé sexuelle des jeunes adultes au Québec, 2013-2014
2014
Opinion et formation des sages-femmes québécoises sur la vaccination
2012
Évaluation de l'implantation du Programme de vaccination contre les virus du papillome humain (VPH) chez les adolescentes du Québec
2011
Avis du Groupe scientifique en immunisation sur les indicateurs des retards vaccinaux au Québec
Plan d'action pour la promotion de la vaccination au Québec
Les services de vaccination dans les pharmacies du Québec
2010
Plan québécois de promotion de la vaccination
Scientific papers
2025
Combined impact of the COVID-19 pandemic and the number of comorbidities on community antibiotic utilisation rates: a population-based retrospective cohort study using linked health administrative data in Quebec, Canada
Immune response after one dose of HPV vaccine among girls and boys and the impact of a second dose given after 3 or more years
Protection Against Persistent HPV-16/18 Infection After Different Number of Doses of Quadrivalent Vaccine in Girls and Young Women: A Randomized Clinical Trial
COVID-19 vaccine hesitancy and perceived post-vaccination adverse event: Findings from a cross-sectional survey
Prevalence of Human Papillomavirus Genotypes in Unvaccinated 16-20-Year-Old Males in Quebec, Canada
Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: Impact of variant replacement and waning protection during 10-month follow-up
2024
Feasibility of interventions to increase HPV vaccination acceptability and coverage in school-based programs: Findings from a pilot study in Quebec, Canada
Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling
Prevalence of Oral Human Papillomavirus Infection Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men in Canada, 2017-2019
Development of Promising Interventions to Improve Human Papillomavirus Vaccination in a School-Based Program in Quebec, Canada: Results From a Formative Evaluation Using a Mixed Methods Design
Development of Promising Interventions to Improve Human Papillomavirus Vaccination in a School-Based Program in Quebec, Canada: Results From a Formative Evaluation Using a Mixed Methods Design
Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis
Impact of interventions to improve HPV vaccination acceptance and uptake in school-based programs: Findings of a pilot project in Quebec
2023
School-based vaccination program against HPV and Hepatitis B: A longitudinal analysis of vaccine coverage between 2015 and 2021 in Quebec
Self-reported Human Papillomavirus Vaccination and Vaccine Effectiveness Among Men Who Have Sex with Men: A Quantitative Bias Analysis
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men
BNT162b2 effectiveness against Delta and Omicron variants of SARS-CoV-2 in adolescents aged 12-17 years, by dosing interval and duration
2022
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
Increases in human papillomavirus vaccine coverage over 12 months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada
Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study
Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada
Impact of the first vaccine dose on COVID-19 and its complications in long-term care facilities and private residences for seniors in Québec, Canada
2021
Human papillomavirus (HPV) vaccination across a cascade of knowledge, willingness, and uptake among gay, bisexual, and other men who have sex with men in Canada's three largest cities
Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada
Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women
Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019
2020
A systematic literature review of the recombinant subunit herpes zoster vaccine use in immunocompromised 18-49 year old patients
Participation in an action research project on vaccine services for children: relationship with vaccine delays
2019
The immune response to a two-dose schedule of quadrivalent HPV vaccine in 9-13 year-old girls: Is it influenced by age, menarche status or body mass index?
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial
Promoting vaccination in maternity wards ─ motivational interview technique reduces hesitancy and enhances intention to vaccinate, results from a multicentre non-controlled pre- and post-intervention RCT-nested study, Quebec, March 2014 to February 2015
A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine
Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol
Challenges and opportunities of school-based HPV vaccination in Canada
2018
Impact of vaccine delays at the 2, 4, 6 and 12 month visits on incomplete vaccination status by 24 months of age in Quebec, Canada
Herpes Zoster Burden in Canadian Provinces: A Narrative Review and Comparison with Quebec Provincial Data
Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial
Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada
Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact
Impact of the addition of new vaccines in the early childhood schedule on vaccine coverage by 24 months of age from 2006 to 2016 in Quebec, Canada
Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccine
2017
Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
2016
"Nature Does Things Well, Why Should We Interfere?": Vaccine Hesitancy Among Mothers
2014
Seasonal influenza vaccination uptake in Quebec, Canada, 2 years after the influenza A(H1N1) pandemic
2013
How do Midwives and Physicians Discuss Childhood Vaccination with Parents?
Immunization services offered in Québec (Canada) pharmacies
Knowledge and attitudes toward vaccination among midwives in Quebec
2012
Determinants of parents' decision to vaccinate their children against rotavirus: results of a longitudinal study
Clinicians' opinions on new vaccination programs implementation
2011
Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children
Acute otitis media and its prevention by immunization: a survey of Canadian pediatricians' knowledge, attitudes and beliefs
Canadian paediatricians' opinions on rotavirus vaccination
A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign
2010
Feasibility and impact of providing feedback to vaccinating medical clinics: evaluating a public health intervention
Human papillomavirus vaccination program
2008
Setting priorities for new vaccination programs by using public health officers and immunization managers opinions
2007
Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs
Government of Quebec
Government of Quebec
